News
ICLR
165.76
-2.68%
-4.56
Medpace leads a rally in CRO space after Q2 beat
Seeking Alpha · 1d ago
ICON Sets Dates for Q2 2026 Earnings Release and Investor Call
TipRanks · 2d ago
ICON updates financial calendar with upcoming second-quarter 2026 earnings call
PUBT · 2d ago
Sequoia Strategy trims Sunbelt, Elevance; exits Liberty Broadband
Seeking Alpha · 4d ago
Weekly Report: what happened at ICLR last week (0713-0717)?
Weekly Report · 4d ago
ICON (ICLR) Stock Looks Fully Priced Despite A 32% Fair Value Gap
Simply Wall St · 6d ago
ICON (ICLR) Could Be 32% Undervalued Following Its 90 Day Rebound
Simply Wall St · 07/15 10:28
Weekly Report: what happened at ICLR last week (0706-0710)?
Weekly Report · 07/13 09:07
SERAFA-1 Trial Update: AstraZeneca and Icon Deepen Their Breast Cancer Bet
TipRanks · 07/10 16:31
BUZZ-U.S. STOCKS ON THE MOVE-Natera, nLIGHT, Micron
Reuters · 07/09 17:42
BUZZ-U.S. STOCKS ON THE MOVE-Natera, nLIGHT, Forte Biosciences
Reuters · 07/09 15:50
BUZZ-U.S. STOCKS ON THE MOVE-Levi's, Meta, PepsiCo
Reuters · 07/09 13:08
BUZZ-U.S. STOCKS ON THE MOVE-Levi, Ionis Pharmaceuticals, Gloo Holdings
Reuters · 07/09 11:37
BUZZ-TD Cowen sees improving demand for contract research firms in Q2 2026
Reuters · 07/09 10:51
RBC Capital Remains a Buy on Icon (ICLR)
TipRanks · 07/09 01:47
ICON Stock and the CRO Trends Shaping Its Next Growth Phase
NASDAQ · 07/08 18:09
Is ICLR Stock a Value Trap or Turnaround After an Earnings Reset?
NASDAQ · 07/07 16:23
ICON Stock Outlook 2026 as Margin Woes Meet a Stronger Backlog Base
NASDAQ · 07/06 18:35
Medpace: The Recovery Narrative Looks Premature
Seeking Alpha · 07/06 18:28
S&P 500 Futures Climb In Premarket Trading; Praxis Precision Meds, IREN Lead
Dow Jones · 07/06 11:30
More
Webull provides a variety of real-time ICLR stock news. You can receive the latest news about ICON plc through multiple platforms. This information may help you make smarter investment decisions.
About ICLR
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.